Skip to content

Drug interactions

Solifenacin + Sunitinib

Severity: Moderate

Solifenacin and Sunitinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sunitinib can prolong the QT interval, and solifenacin can contribute further, raising the risk of torsades de pointes. Sunitinib is also a CYP3A4 substrate, but the main concern is cardiac repolarization.

What this interaction means in plain words

Solifenacin and Sunitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Solifenacin belongs to Genitourinary; Sunitinib belongs to Oncology.

Evidence level: Low

Why it happens

Additive QT prolongation.

What to do

Check the ECG and electrolytes at baseline and periodically during therapy. Correct hypokalemia and hypomagnesemia and avoid further QT-prolonging drugs.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Solifenacin and Sunitinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Solifenacin with Sunitinib?

MediHelp rates the interaction as moderate. Solifenacin and Sunitinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Sunitinib can prolong the QT interval, and solifenacin can contribute further, raising the risk of torsades de pointes. Sunitinib is also a CYP3A4 substrate, but the main concern is cardiac repolarization.

How serious is the interaction between Solifenacin and Sunitinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check the ECG and electrolytes at baseline and periodically during therapy. Correct hypokalemia and hypomagnesemia and avoid further QT-prolonging drugs.

What other medicines interact with Solifenacin?

MediHelp also lists interactions of Solifenacin with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Solifenacin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in